Talumil

Medicinal product

(Invented) name

Talumil

Active substance (s)

Solifenacino sukcinatas/Tamsulozino hidrochloridas

Strength

6 mg/0,4 mg

Pharmaceutical form

modifikuoto atpalaidavimo tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G04CA53, Tamsulosin and solifenacin

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-06-26

Date of renewal

Documents

2670_Talumil 6mg-0,4mg_mod_atpal_tab_PZ_2025-06-26.docx

2670_Talumil 6mg-0,4mg_mod_atpal_tab_PL_2025-06-26.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Solifenacino sukcinatas	6 mg
Tamsulozino hidrochloridas	0,4 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117880	103985	1103985	lizdinė plokštelė	N10		Receptinis	LT/L/25/2670/001	Netiekiama	-	-	No	-	-	Download
117881	103986	1103986	lizdinė plokštelė	N30		Receptinis	LT/L/25/2670/002	Netiekiama	-	-	No	-	-
117882	103987	1103987	lizdinė plokštelė	N50		Receptinis	LT/L/25/2670/003	Netiekiama	-	-	No	-	-
117883	103988	1103988	lizdinė plokštelė	N90		Receptinis	LT/L/25/2670/004	Netiekiama	-	-	No	-	-
117884	103989	1103989	lizdinė plokštelė	N100		Receptinis	LT/L/25/2670/005	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-06-26	Registruotas